| |
| |
|
| Insider
Information: |
Anand Bhaskar |
| Relationship: |
Officer |
| City: |
Plano |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
109,400 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$480,266 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
109,400 |
|
|
| Total
Value |
$480,266 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Reata Pharmaceuticals Inc |
RETA |
SVP, Chief Accounting ... |
2023-09-26 |
0 |
|
0 |
Premium* |
|
|
Summit Therapeutics Inc |
SMMT |
Officer |
2024-04-02 |
109,400 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SMMT |
Summit Therapeutics Inc |
Chief Accounting OfficerOffice |
• – – |
2024-04-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
109,400 |
|
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-09-26 |
4 |
D |
$0.00 |
$0 |
D/D |
(24,089) |
0 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-09-05 |
4 |
S |
$169.20 |
$68,695 |
D/D |
(406) |
24,089 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-08-16 |
4 |
S |
$168.42 |
$35,368 |
D/D |
(210) |
24,495 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-08-15 |
4 |
S |
$169.06 |
$32,628 |
D/D |
(193) |
24,705 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-06-14 |
4 |
S |
$102.11 |
$239,248 |
D/D |
(2,343) |
24,898 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-06-14 |
4 |
OE |
$27.32 |
$42,674 |
D/D |
1,562 |
27,241 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-05-16 |
4 |
S |
$81.10 |
$11,030 |
D/D |
(136) |
25,679 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-05-15 |
4 |
S |
$85.98 |
$81,684 |
D/D |
(950) |
25,815 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-03-07 |
4 |
S |
$84.58 |
$13,956 |
D/D |
(165) |
26,765 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-03-03 |
4 |
S |
$87.47 |
$71,725 |
D/D |
(820) |
26,930 |
0 |
% |
|
| RETA |
Reata Pharmaceuticals Inc |
SVP, Chief Accounting Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
27,750 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,250 |
24,750 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting Officer |
• – – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
16,500 |
0 |
- |
|
| RETA |
Reata Pharmaceuticals Inc |
VP, Chief Accounting OfficerOf |
• – – |
2021-11-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,000 |
|
% |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
